Security key
034569103
Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB)
CUSIP: 034569103
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 41,587,315
- Total 13F shares
- 22,570,347
- Share change
- +15,226,613
- Total reported value
- $37,311,560
- Price per share
- $1.68
- Number of holders
- 15
- Value change
- +$24,974,043
- Number of buys
- 8
- Number of sells
- 4
Report period
Q4 2024
Institutions
15
Top holders
10
ANEB full security history
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Anebulo Pharmaceuticals, Inc. SEC filings
Anebulo Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 034569103
Recent filing periods:
Top shareholders of ANEB - Anebulo Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MANGROVE PARTNERS IM, LLC |
13D/G
|
— |
6.2%
|
2,525,252
|
$2,979,797 | $0 | 31 Dec 2024 | |
| 22NW, LP |
13F
|
Company |
13%
|
5,366,290
|
$10,356,940 | — | 30 Sep 2024 | |
| LVW Advisors, LLC |
13F
|
Company |
1.5%
|
641,039
|
$1,237,206 | — | 30 Sep 2024 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
1.2%
|
511,073
|
$986,371 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.96%
|
399,219
|
$770,493 | — | 30 Sep 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.38%
|
157,862
|
$304,675 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.37%
|
154,036
|
$297,289 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.21%
|
87,790
|
$169,474 | — | 30 Sep 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
18,978
|
$36,628 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.01%
|
3,905
|
$7,536 | — | 30 Sep 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
2,694
|
$5,199 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
763
|
$1,473 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
76
|
$147 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
9
|
$17 | — | 30 Sep 2024 | |
| Simon Allen |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
70,246
|
— | — | 09 Dec 2022 | |
| Karah Herdman Parschauer |
3/4/5
|
Director |
—
class O/S missing
|
30,425
|
— | — | 21 Apr 2022 |
Institutional Holders of Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) as of Q4 2024
As of 31 Dec 2024,
Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,570,347 shares.
The largest 10 holders included
22NW, LP, Nantahala Capital Management, LLC, MANGROVE PARTNERS IM, LLC, LVW Advisors, LLC, MORGAN STANLEY, Ikarian Capital, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, KING LUTHER CAPITAL MANAGEMENT CORP, and BOOTHBAY FUND MANAGEMENT, LLC.
This page lists
15
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
13
Q4 2024 holders
15
Holder diff
2
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.